Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: prospective analysis from the French Pompe RegistrySemplicini C, De Antonio M, Taouagh N, et al.
Journal of inherited metabolic disease, 2020
Respiratory function during enzyme replacement therapy in late-onset Pompe disease: longitudinal course, prognostic factors, and the impact of time from diagnosis to treatment startStockton DW, Kishnani P, van der Ploeg A, et al.
Journal of neurology, 2020
Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)